[HTML][HTML] Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?

NM Dixit, A Churchill, A Nsair, JJ Hsu - American heart journal plus …, 2021 - Elsevier
Abstract Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms> 3–4
weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from …

[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review

CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …

Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study

I Katsoularis, O Fonseca-Rodríguez, P Farrington… - bmj, 2022 - bmj.com
Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding
after covid-19. Design Self-controlled case series and matched cohort study. Setting …

[HTML][HTML] Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study

I Katsoularis, O Fonseca-Rodríguez, P Farrington… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a complex disease targeting many organs. Previous studies
highlight COVID-19 as a probable risk factor for acute cardiovascular complications. We …

[HTML][HTML] IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

C Prelli Bozzo, R Nchioua, M Volcic, L Koepke… - Nature …, 2021 - nature.com
Interferon-induced transmembrane proteins (IFITMs 1, 2 and 3) can restrict viral pathogens,
but pro-and anti-viral activities have been reported for coronaviruses. Here, we show that …

[HTML][HTML] Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK

E Rezel-Potts, A Douiri, X Sun, PJ Chowienczyk… - PLoS …, 2022 - journals.plos.org
Background Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …

“Mask up to keep it up”: Preliminary evidence of the association between erectile dysfunction and COVID‐19

A Sansone, D Mollaioli, G Ciocca, E Colonnello… - …, 2021 - Wiley Online Library
Background Erectile dysfunction (ED), as the hallmark of endothelial dysfunction, could be a
short‐or long‐term complication of COVID‐19. Additionally, being ED a clinical marker and …

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

P Clavario, V De Marzo, R Lotti, C Barbara… - International journal of …, 2021 - Elsevier
Background Long-term effects of Coronavirus Disease of 2019 (COVID-19) are of utmost
relevance. We aimed to determine: 1) the functional capacity of COVID-19 survivors by …

[HTML][HTML] The pulmonary pathology of COVID-19

H Bösmüller, M Matter, F Fend, A Tzankov - Virchows Archiv, 2021 - Springer
The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused
by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in …

[HTML][HTML] Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19

C Matsumoto, S Shibata, T Kishi, S Morimoto… - Hypertension …, 2023 - nature.com
Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …